English
Back
Download
Log in to access Online Inquiry
Back to the Top

$Kodiak Sciences (KOD.US)$ announced first time results of K...

$Kodiak Sciences (KOD.US)$ announced first time results of KSI-501 ABC Phase 1 study. The data outlined safety and biocativity of KSI-501, along with high binding affinity and bioactivity against VEGF and IL-6.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
8301 Views
Comment
Sign in to post a comment
    16
    Followers
    66
    Following
    99
    Visitors
    Follow